|
Work
in progress?
Indian Pharmacopoeia is unlike its American and British counterparts
and is still struggling for freedom and autonomy. But many
critics say that it is still in its infancy and offers great
promise. Sapna Dogra investigates
Upfront
Zydus
enters generics market in Japan
Making a foray in the generics market of Japan, the Zydus
group announced the establishment of 'Zydus Pharma'. A wholly
owned subsidiary, Zydus Pharma will market formulation generics
and API in Japan.
Lupin
gets USFDA approval for Ceftriaxone
Lupin announced that the USFDA has approved the company's
ANDA for its Ceftriaxone injection ten gram vials. Ceftriaxone
is the generic equivalent of Rocephin, which is marketed by
Roche.
Torrent
Pharma launches Nexpro Fast
Torrent Pharma has launched Nexpro Fast, a Proton Pump Inhibitor
(PPI), for the first time in India to treat peptic ulcers
and Gastro Esophageal Reflux Disease (GERD). It is said that
the clinical action of Nexpro Fast is faster and longer lasting
than the existing drugs in this category.
HiMedia
signs agreement with VWR International
HiMedia Laboratories has entered into a joint distribution
agreement with VWR International to support the chemicals
and laboratory supplies requirements of the rapidly expanding
pharmaceutical and biotech industry in the sub-continent.
Eli
Lilly India to launch Anti Cancer Drug ‘Alimta’
Eli Lilly & Company, India has announced the launch of
Alimta (pemetrexed disodium), for use in combination with
cisplatin for the treatment of patients with malignant pleural
mesothelioma (MPM)—a rare type of cancer.
Ethypharm
licenses cardio product to Ranbaxy
Ethypharm India anno-unced the out-licensing and supply contract
agreements with Ranbaxy for a fixed dose combination of Fenofibrate
micronized 160 milligram and Atorvastatin 10 milligram.
Sun
rises in the East
The global biopharmaceutical industry is ailing. The main
symptom is a deceleration in new drug development. So says
the Boston Consulting Group (BCG) report 'Looking Eastward'.
‘Higher
value products are driving growth'
Raman Mangalorekar, Principal, Pharmaceuticals, AT Kearney
talks to Nandini Patwardhan about changing business models
for the evolving pharma retail industry
India
on the global map
"No country in the world is equipped with advantages
as that of India," said John Morris, Global Chair-Pharma,
KPMG, United Kingdom at the CII Pharma Summit 2006.
Pharma
Vision 2006
The SIES College of Management Studies's (SIESCOMS)'s Post
Graduate Diploma in Pharmaceutical Management (PGDPM) programme
in collaboration with the Indian Drug Manufacturers Association
organised Pharma Vision 2006.
Upcoming
Events
|
